These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 9891532)

  • 21. Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study.
    Kim HS; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW
    Gynecol Oncol; 2010 Sep; 118(3):283-8. PubMed ID: 20541245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.
    Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM
    Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of tumor-associated trypsin inhibitor (TATI) in subjects with gastrointestinal diseases. Preliminary data].
    Piantino P; Mosso R; Polloni R; Cerchier A; Gennaretti G; Daziano E
    Minerva Med; 1989 Mar; 80(3):199-203. PubMed ID: 2717042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients.
    van Dalen A; Favier J; Baumgartner L; Hasholzner U; de Bruijn H; Dobbler D; Dombi VH; Fink D; Giai M; McGing P; Harlozinska A; Kainz C; Markowska J; Molina R; Sturgeon C; Einarsson R
    Anticancer Res; 1999; 19(4A):2523-6. PubMed ID: 10470187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma.
    Saarelainen SK; Peltonen N; Lehtimäki T; Perheentupa A; Vuento MH; Mäenpää JU
    Am J Obstet Gynecol; 2013 Aug; 209(2):142.e1-6. PubMed ID: 23583212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of CA 125 serum level in discrimination between benign and malignant masses in the pelvis.
    Milojkovic M; Hrgovic Z; Hrgovic I; Jonat W; Maass N; Buković D
    Arch Gynecol Obstet; 2004 Mar; 269(3):176-80. PubMed ID: 14557888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of serum tetranectin, CA 125, and a combined index as tumor markers in women with pelvic tumors.
    Høgdall CK; Mogensen O; Tabor A; Mogensen B; Jakobsen AK; Nørgaard-Pedersen B; Larsen SO; Clemmensen I
    Gynecol Oncol; 1995 Jan; 56(1):22-8. PubMed ID: 7821842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.
    Paju A; Hotakainen K; Cao Y; Laurila T; Gadaleanu V; Hemminki A; Stenman UH; Bjartell A
    Eur Urol; 2007 Dec; 52(6):1670-9. PubMed ID: 17306443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum CA-125 measurements > 65 U/mL. Clinical value.
    Eltabbakh GH; Belinson JL; Kennedy AW; Gupta M; Webster K; Blumenson LE
    J Reprod Med; 1997 Oct; 42(10):617-24. PubMed ID: 9350014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
    Cole LA; Tanaka A; Kim GS; Park SY; Koh MW; Schwartz PE; Chambers JT; Nam JH
    Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The plasma levels and diagnostic utility of selected hematopoietic growth factors in endometrial cancer patients and with myoma uteri].
    Ławicki S; Bedkowska GE; Gacuta-Szumarska E; Czygier M; Szmitkowski M
    Pol Merkur Lekarski; 2010 May; 28(167):354-8. PubMed ID: 20568396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative determination of CASA (Cancer Associated Serum Antigen) and CA-125 for the discrimination between benign and malignant pelvic tumor mass: a prospective study.
    Sehouli J; Akdogan Z; Heinze T; Könsgen D; Stengel D; Mustea A; Lichtenegger W
    Anticancer Res; 2003; 23(2A):1115-8. PubMed ID: 12820357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-associated trypsin inhibitor (TATI) and renal function.
    Tramonti G; Ferdeghini M; Donadio C; Annichiarico C; Norpoth M; Bianchi R; Bianchi C
    Kidney Int Suppl; 1997 Dec; 63():S179-81. PubMed ID: 9453997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer.
    Santala M; Talvensaari-Mattila A; Kauppila A
    Anticancer Res; 2003; 23(3C):3097-103. PubMed ID: 12926169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of final histology in patients with endometrial cancer.
    Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
    Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of the TAG-72 (CA 72-4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker].
    Zeimet AG; Guadagni F; Marth C; Amato T; Müller-Holzner E; Huter O; Daxenbichler G; Dapunt O
    Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):195-9. PubMed ID: 7789707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue polypeptide specific antigen (TPS) and carbohydrate antigen 125 (CA-125) in the early prediction of recurrent ovarian cancer.
    Yeh LS; Hung YC; Kao A; Lin CC; Lee CC
    Anticancer Res; 2002; 22(6B):3669-71. PubMed ID: 12552974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.